US2020360289A1PendingUtilityA1

Freeze-dried product and gas-filled microvesicles suspension

Assignee: BRACCO SUISSE SAPriority: May 15, 2019Filed: Feb 11, 2020Published: Nov 19, 2020
Est. expiryMay 15, 2039(~12.8 yrs left)· nominal 20-yr term from priority
A61K 49/223A61K 9/1277A61K 9/1271A61K 9/10A61K 9/19
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Lipid formulation particularly for preparing stable gas-filled microvesicles, comprising distearoyl-phosphatidylcholine (DSPC), dipalmitoylphosphatidylethanolamine-PEG5000 (DPPE-PEG5000) and palmitic acid in an advantageous relative molar ratio. The formulation is useful in particular for therapeutic application with ultrasounds.

Claims

exact text as granted — not AI-modified
1 . A freeze-dried formulation, for preparing gas-filled microvesicles, comprising a lipid mixture of DSPC, DPPE-PEG and palmitic acid in a respective molar amount of 65-85/4-10/8-22. 
     
     
         2 . The freeze-dried formulation of  claim 1  wherein said respective molar amount is of 70-80/5-9/12-21. 
     
     
         3 . The freeze-dried formulation of  claim 1  wherein said respective molar amount is of 72-76/6-8/15-20. 
     
     
         4 . The freeze-dried formulation of  claim 1  wherein said respective molar amount is of 74 (+/−1)/7.5 (+/−0.5)/18.5(+/−1). 
     
     
         5 . The freeze-dried formulation of any of the preceding  claims 1  to  4  further comprising a freeze-drying protective component. 
     
     
         6 . The freeze-dried formulation according to  claim 5 , wherein freeze-drying protective component is PEG4000. 
     
     
         7 . The freeze-dried formulation according to  claim 6 , wherein the weight of the lipid mixture is of from 0.08% to 0.3% with respect to the weight of PEG4000. 
     
     
         8 . The freeze-dried formulation according to  claim 7  wherein said weight is of from 0.10% to 0.20%. 
     
     
         9 . The freeze-dried formulation according to  claim 7  wherein said weight is of from 0.12% to 0.18% by weight 
     
     
         10 . The freeze-dried formulation according to  claim 7  wherein said weight is of about 0.16%. 
     
     
         11 . A suspension of gas-filled microvesicles wherein said microvesicles comprise a mixture of DSPC, DPPE-PEG and palmitic acid in a respective molar amount of 65-85/4-10/8-22. 
     
     
         12 . The suspension of  claim 11  wherein said respective molar amount is of 70-80/5-9/12-21. 
     
     
         13 . The suspension of  claim 11  wherein said respective molar amount is of 72-76/6-8/15-20. 
     
     
         14 . The suspension of  claim 11  wherein said respective molar amount is of 74 (+/−1)/7.5 (+/−0.5)/18.5(+/−1).

Join the waitlist — get patent alerts

Track US2020360289A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.